SOLIQUA 100/33 FDA approval date

The FDA approved SOLIQUA 100/33 on 21 Nov 2016.

FDA approval date
21 Nov 2016

Drug identity has not yet been verified against registry records

Also recorded as INSULIN GLARGINE; LIXISENATIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-11-21DaySOLIQUA 100/33FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA208673", "applicant_as_listed_by_fda": "SANOFI-AVENTIS US", "brand_names": ["SOLIQUA 100/33"], "active_ingredients": ["INSULIN GLARGINE", "LIXISENATIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20161121", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026